| MSAAX | VTIAX | MSAAX / VTIAX | |
| Total Expense Ratio | 2.00 | 0.09 | 2,222% |
| Annual Report Gross Expense Ratio | 2.91 | 0.09 | 3,233% |
| Fund Existence | 11 years | 15 years | - |
| Gain YTD | 8.111 | 6.538 | 124% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 182M | 574B | 0% |
| Annual Yield % from dividends | 0.48 | 2.98 | 16% |
| Returns for 1 year | 27.72 | 34.55 | 80% |
| Returns for 3 years | 35.59 | 47.44 | 75% |
| Returns for 5 years | 6.06 | 34.64 | 17% |
| Returns for 10 years | 86.42 | 109.80 | 79% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIDFX | 59.76 | 0.32 | +0.54% |
| Marsico Midcap Growth Focus Instl | |||
| FBTTX | 34.88 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||
| VADCX | 68.61 | -0.15 | -0.22% |
| Invesco Equally-Wtd S&P 500 C | |||
| CLTCX | 15.07 | -0.08 | -0.53% |
| Catalyst Tactical Allocation Fund C | |||
| THCGX | 31.45 | -0.65 | -2.02% |
| Thornburg Small/Mid Cap Growth A | |||